Responsibilities of Data Monitoring Committees: Consensus Recommendations

Background: A data monitoring committee (DMC) has special responsibilities for protecting the safety of clinical trial participants. Few guidance documents are available that address the operations and mechanics of establishing, serving on, or reporting to a DMC. This article provides a practical gu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Therapeutic innovation & regulatory science 2016-09, Vol.50 (5), p.648-659
Hauptverfasser: Bierer, Barbara E., Li, Rebecca, Seltzer, Jonathan, Sleeper, Lynn A., Frank, Elizabeth, Knirsch, Charles, Aldinger, Carmen E., Levine, Robert J., Massaro, Joe, Shah, Amish, Barnes, Mark, Snapinn, Steven, Wittes, Janet
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 659
container_issue 5
container_start_page 648
container_title Therapeutic innovation & regulatory science
container_volume 50
creator Bierer, Barbara E.
Li, Rebecca
Seltzer, Jonathan
Sleeper, Lynn A.
Frank, Elizabeth
Knirsch, Charles
Aldinger, Carmen E.
Levine, Robert J.
Massaro, Joe
Shah, Amish
Barnes, Mark
Snapinn, Steven
Wittes, Janet
description Background: A data monitoring committee (DMC) has special responsibilities for protecting the safety of clinical trial participants. Few guidance documents are available that address the operations and mechanics of establishing, serving on, or reporting to a DMC. This article provides a practical guide to sponsors, institutions, and individuals responsible for, or serving on, a DMC. Methods: A workgroup of professionals from academia and not-for-profit and commercial organizations that included investigators, statisticians, patient advocates, and ethicists met to define the essential elements of planning, coordinating, and populating a DMC. All members of the group have formed, served on, advised, or worked with DMCs. Results: The group outlined the objectives and mechanics of running a DMC, including operational and practical considerations, membership characteristics, roles, members’ liability, and indemnification. Further, it delineated the roles and responsibilities of each DMC member. Conclusions: The group recommended practices for each phase of the DMC process from inception through execution of a clinical trial, with appropriate considerations for confidentiality. The group’s practical guidance should assist in comprehensive oversight of appropriate clinical trials and should help DMC members execute their obligations with greater assurance.
doi_str_mv 10.1177/2168479016646812
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2179219706</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_2168479016646812</sage_id><sourcerecordid>1827909169</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-c653efa38923770aa6e3c7afdd4f4359ffce8b27c84060d3b1f1b59d57639a693</originalsourceid><addsrcrecordid>eNqNkM1LwzAYh4MobszdPUnBi5fOvEmaj6PMT5gIoueStsnIaJvZtAf_ezO3iQiiuSQkz-_3kgehU8AzACEuCXDJhMLAOeMSyAEab65SJjE73J_j-whNQ1jhuJTMBJHHaEQxoSA4HqPZswlr3wZXuNr1zoTE2-Ra9zp59K3rfefaZTL3TeP63phwgo6sroOZ7vYJer29eZnfp4unu4f51SItGcN9WvKMGqupVIQKgbXmhpZC26piltFMWVsaWRBRSoY5rmgBFopMVZngVGmu6ARdbHvXnX8bTOjzxoXS1LVujR9CTkAoAkpg_icKkkQJCj5bz3-gKz90bfxIpEBRnBFGI4W3VNn5EDpj83XnGt2954Dzjfn8p_kYOdsVD0Vjqq_A3nMEYAuE9cao6b5N_r003WX00vyD_wCuT5bI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1819305243</pqid></control><display><type>article</type><title>Responsibilities of Data Monitoring Committees: Consensus Recommendations</title><source>SAGE Complete A-Z List</source><source>Alma/SFX Local Collection</source><source>SpringerLink Journals - AutoHoldings</source><creator>Bierer, Barbara E. ; Li, Rebecca ; Seltzer, Jonathan ; Sleeper, Lynn A. ; Frank, Elizabeth ; Knirsch, Charles ; Aldinger, Carmen E. ; Levine, Robert J. ; Massaro, Joe ; Shah, Amish ; Barnes, Mark ; Snapinn, Steven ; Wittes, Janet</creator><creatorcontrib>Bierer, Barbara E. ; Li, Rebecca ; Seltzer, Jonathan ; Sleeper, Lynn A. ; Frank, Elizabeth ; Knirsch, Charles ; Aldinger, Carmen E. ; Levine, Robert J. ; Massaro, Joe ; Shah, Amish ; Barnes, Mark ; Snapinn, Steven ; Wittes, Janet</creatorcontrib><description>Background: A data monitoring committee (DMC) has special responsibilities for protecting the safety of clinical trial participants. Few guidance documents are available that address the operations and mechanics of establishing, serving on, or reporting to a DMC. This article provides a practical guide to sponsors, institutions, and individuals responsible for, or serving on, a DMC. Methods: A workgroup of professionals from academia and not-for-profit and commercial organizations that included investigators, statisticians, patient advocates, and ethicists met to define the essential elements of planning, coordinating, and populating a DMC. All members of the group have formed, served on, advised, or worked with DMCs. Results: The group outlined the objectives and mechanics of running a DMC, including operational and practical considerations, membership characteristics, roles, members’ liability, and indemnification. Further, it delineated the roles and responsibilities of each DMC member. Conclusions: The group recommended practices for each phase of the DMC process from inception through execution of a clinical trial, with appropriate considerations for confidentiality. The group’s practical guidance should assist in comprehensive oversight of appropriate clinical trials and should help DMC members execute their obligations with greater assurance.</description><identifier>ISSN: 2168-4790</identifier><identifier>EISSN: 2168-4804</identifier><identifier>DOI: 10.1177/2168479016646812</identifier><identifier>PMID: 30231760</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Authorship ; Clinical trials ; Clinical Trials: Analytical Report ; Committees ; Corporate sponsorship ; Drug Safety and Pharmacovigilance ; Mortality ; Patient safety ; Pharmacotherapy ; Pharmacy ; Professional relationships ; Responsibilities ; Statistical analysis ; Studies</subject><ispartof>Therapeutic innovation &amp; regulatory science, 2016-09, Vol.50 (5), p.648-659</ispartof><rights>The Author(s) 2016</rights><rights>Drug Information Association, Inc 2016</rights><rights>Copyright Drug Information Association Sep 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-c653efa38923770aa6e3c7afdd4f4359ffce8b27c84060d3b1f1b59d57639a693</citedby><cites>FETCH-LOGICAL-c440t-c653efa38923770aa6e3c7afdd4f4359ffce8b27c84060d3b1f1b59d57639a693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/2168479016646812$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/2168479016646812$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21818,27923,27924,41487,42556,43620,43621,51318</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30231760$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bierer, Barbara E.</creatorcontrib><creatorcontrib>Li, Rebecca</creatorcontrib><creatorcontrib>Seltzer, Jonathan</creatorcontrib><creatorcontrib>Sleeper, Lynn A.</creatorcontrib><creatorcontrib>Frank, Elizabeth</creatorcontrib><creatorcontrib>Knirsch, Charles</creatorcontrib><creatorcontrib>Aldinger, Carmen E.</creatorcontrib><creatorcontrib>Levine, Robert J.</creatorcontrib><creatorcontrib>Massaro, Joe</creatorcontrib><creatorcontrib>Shah, Amish</creatorcontrib><creatorcontrib>Barnes, Mark</creatorcontrib><creatorcontrib>Snapinn, Steven</creatorcontrib><creatorcontrib>Wittes, Janet</creatorcontrib><title>Responsibilities of Data Monitoring Committees: Consensus Recommendations</title><title>Therapeutic innovation &amp; regulatory science</title><addtitle>Ther Innov Regul Sci</addtitle><addtitle>Ther Innov Regul Sci</addtitle><description>Background: A data monitoring committee (DMC) has special responsibilities for protecting the safety of clinical trial participants. Few guidance documents are available that address the operations and mechanics of establishing, serving on, or reporting to a DMC. This article provides a practical guide to sponsors, institutions, and individuals responsible for, or serving on, a DMC. Methods: A workgroup of professionals from academia and not-for-profit and commercial organizations that included investigators, statisticians, patient advocates, and ethicists met to define the essential elements of planning, coordinating, and populating a DMC. All members of the group have formed, served on, advised, or worked with DMCs. Results: The group outlined the objectives and mechanics of running a DMC, including operational and practical considerations, membership characteristics, roles, members’ liability, and indemnification. Further, it delineated the roles and responsibilities of each DMC member. Conclusions: The group recommended practices for each phase of the DMC process from inception through execution of a clinical trial, with appropriate considerations for confidentiality. The group’s practical guidance should assist in comprehensive oversight of appropriate clinical trials and should help DMC members execute their obligations with greater assurance.</description><subject>Authorship</subject><subject>Clinical trials</subject><subject>Clinical Trials: Analytical Report</subject><subject>Committees</subject><subject>Corporate sponsorship</subject><subject>Drug Safety and Pharmacovigilance</subject><subject>Mortality</subject><subject>Patient safety</subject><subject>Pharmacotherapy</subject><subject>Pharmacy</subject><subject>Professional relationships</subject><subject>Responsibilities</subject><subject>Statistical analysis</subject><subject>Studies</subject><issn>2168-4790</issn><issn>2168-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkM1LwzAYh4MobszdPUnBi5fOvEmaj6PMT5gIoueStsnIaJvZtAf_ezO3iQiiuSQkz-_3kgehU8AzACEuCXDJhMLAOeMSyAEab65SJjE73J_j-whNQ1jhuJTMBJHHaEQxoSA4HqPZswlr3wZXuNr1zoTE2-Ra9zp59K3rfefaZTL3TeP63phwgo6sroOZ7vYJer29eZnfp4unu4f51SItGcN9WvKMGqupVIQKgbXmhpZC26piltFMWVsaWRBRSoY5rmgBFopMVZngVGmu6ARdbHvXnX8bTOjzxoXS1LVujR9CTkAoAkpg_icKkkQJCj5bz3-gKz90bfxIpEBRnBFGI4W3VNn5EDpj83XnGt2954Dzjfn8p_kYOdsVD0Vjqq_A3nMEYAuE9cao6b5N_r003WX00vyD_wCuT5bI</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Bierer, Barbara E.</creator><creator>Li, Rebecca</creator><creator>Seltzer, Jonathan</creator><creator>Sleeper, Lynn A.</creator><creator>Frank, Elizabeth</creator><creator>Knirsch, Charles</creator><creator>Aldinger, Carmen E.</creator><creator>Levine, Robert J.</creator><creator>Massaro, Joe</creator><creator>Shah, Amish</creator><creator>Barnes, Mark</creator><creator>Snapinn, Steven</creator><creator>Wittes, Janet</creator><general>SAGE Publications</general><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20160901</creationdate><title>Responsibilities of Data Monitoring Committees</title><author>Bierer, Barbara E. ; Li, Rebecca ; Seltzer, Jonathan ; Sleeper, Lynn A. ; Frank, Elizabeth ; Knirsch, Charles ; Aldinger, Carmen E. ; Levine, Robert J. ; Massaro, Joe ; Shah, Amish ; Barnes, Mark ; Snapinn, Steven ; Wittes, Janet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-c653efa38923770aa6e3c7afdd4f4359ffce8b27c84060d3b1f1b59d57639a693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Authorship</topic><topic>Clinical trials</topic><topic>Clinical Trials: Analytical Report</topic><topic>Committees</topic><topic>Corporate sponsorship</topic><topic>Drug Safety and Pharmacovigilance</topic><topic>Mortality</topic><topic>Patient safety</topic><topic>Pharmacotherapy</topic><topic>Pharmacy</topic><topic>Professional relationships</topic><topic>Responsibilities</topic><topic>Statistical analysis</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bierer, Barbara E.</creatorcontrib><creatorcontrib>Li, Rebecca</creatorcontrib><creatorcontrib>Seltzer, Jonathan</creatorcontrib><creatorcontrib>Sleeper, Lynn A.</creatorcontrib><creatorcontrib>Frank, Elizabeth</creatorcontrib><creatorcontrib>Knirsch, Charles</creatorcontrib><creatorcontrib>Aldinger, Carmen E.</creatorcontrib><creatorcontrib>Levine, Robert J.</creatorcontrib><creatorcontrib>Massaro, Joe</creatorcontrib><creatorcontrib>Shah, Amish</creatorcontrib><creatorcontrib>Barnes, Mark</creatorcontrib><creatorcontrib>Snapinn, Steven</creatorcontrib><creatorcontrib>Wittes, Janet</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Toxicology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Therapeutic innovation &amp; regulatory science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bierer, Barbara E.</au><au>Li, Rebecca</au><au>Seltzer, Jonathan</au><au>Sleeper, Lynn A.</au><au>Frank, Elizabeth</au><au>Knirsch, Charles</au><au>Aldinger, Carmen E.</au><au>Levine, Robert J.</au><au>Massaro, Joe</au><au>Shah, Amish</au><au>Barnes, Mark</au><au>Snapinn, Steven</au><au>Wittes, Janet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Responsibilities of Data Monitoring Committees: Consensus Recommendations</atitle><jtitle>Therapeutic innovation &amp; regulatory science</jtitle><stitle>Ther Innov Regul Sci</stitle><addtitle>Ther Innov Regul Sci</addtitle><date>2016-09-01</date><risdate>2016</risdate><volume>50</volume><issue>5</issue><spage>648</spage><epage>659</epage><pages>648-659</pages><issn>2168-4790</issn><eissn>2168-4804</eissn><abstract>Background: A data monitoring committee (DMC) has special responsibilities for protecting the safety of clinical trial participants. Few guidance documents are available that address the operations and mechanics of establishing, serving on, or reporting to a DMC. This article provides a practical guide to sponsors, institutions, and individuals responsible for, or serving on, a DMC. Methods: A workgroup of professionals from academia and not-for-profit and commercial organizations that included investigators, statisticians, patient advocates, and ethicists met to define the essential elements of planning, coordinating, and populating a DMC. All members of the group have formed, served on, advised, or worked with DMCs. Results: The group outlined the objectives and mechanics of running a DMC, including operational and practical considerations, membership characteristics, roles, members’ liability, and indemnification. Further, it delineated the roles and responsibilities of each DMC member. Conclusions: The group recommended practices for each phase of the DMC process from inception through execution of a clinical trial, with appropriate considerations for confidentiality. The group’s practical guidance should assist in comprehensive oversight of appropriate clinical trials and should help DMC members execute their obligations with greater assurance.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>30231760</pmid><doi>10.1177/2168479016646812</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2168-4790
ispartof Therapeutic innovation & regulatory science, 2016-09, Vol.50 (5), p.648-659
issn 2168-4790
2168-4804
language eng
recordid cdi_proquest_miscellaneous_2179219706
source SAGE Complete A-Z List; Alma/SFX Local Collection; SpringerLink Journals - AutoHoldings
subjects Authorship
Clinical trials
Clinical Trials: Analytical Report
Committees
Corporate sponsorship
Drug Safety and Pharmacovigilance
Mortality
Patient safety
Pharmacotherapy
Pharmacy
Professional relationships
Responsibilities
Statistical analysis
Studies
title Responsibilities of Data Monitoring Committees: Consensus Recommendations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T22%3A32%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Responsibilities%20of%20Data%20Monitoring%20Committees:%20Consensus%20Recommendations&rft.jtitle=Therapeutic%20innovation%20&%20regulatory%20science&rft.au=Bierer,%20Barbara%20E.&rft.date=2016-09-01&rft.volume=50&rft.issue=5&rft.spage=648&rft.epage=659&rft.pages=648-659&rft.issn=2168-4790&rft.eissn=2168-4804&rft_id=info:doi/10.1177/2168479016646812&rft_dat=%3Cproquest_cross%3E1827909169%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1819305243&rft_id=info:pmid/30231760&rft_sage_id=10.1177_2168479016646812&rfr_iscdi=true